{"id":17587,"date":"2026-11-04T18:12:37","date_gmt":"2026-11-04T15:12:37","guid":{"rendered":"https:\/\/www.ortaakarsu.net\/?page_id=17587"},"modified":"2026-11-04T18:12:37","modified_gmt":"2026-11-04T15:12:37","slug":"english-interaction-pimozide-ziprasidone","status":"publish","type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=17587","title":{"rendered":"Pimozide and Ziprasidone: interaction and safety"},"content":{"rendered":"<h2>Interaction mechanism<\/h2>\n<p>Combining antipsychotics can increase central, extrapyramidal and cardiac adverse effects. Pimozide combined with an established systemic QT-prolonging medicine presents a serious arrhythmia risk.<\/p>\n<h2>Clinical significance and safety<\/h2>\n<p>Pimozide and Ziprasidone: Combining antipsychotics can increase central, extrapyramidal and cardiac adverse effects. Pimozide combined with an established systemic QT-prolonging medicine presents a serious arrhythmia risk. This combination is contraindicated under the cited pimozide product information for established QT-prolonging partners. It needs prompt prescriber or pharmacist review, not self-directed dose changes. Heart disease, a slow pulse and low potassium or magnesium can increase concern. A clinician determines whether ECG or electrolyte checks are needed. Fainting or new irregular palpitations require urgent assessment. Concurrent antipsychotic treatment or a planned switch requires specialist review of movement symptoms, alertness, balance and cardiac risk. A class precaution is not evidence that all such combinations are absolutely contraindicated.<\/p>\n<h2>Using this information<\/h2>\n<p>This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pimozide and Ziprasidone: Combining antipsychotics can increase central, extrapyramidal and cardiac adverse effects. Pimozide combined with an established systemic QT-prolongi\u2026<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-17587","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages\/17587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17587"}],"version-history":[{"count":0,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages\/17587\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}